Cervical Cancer Screening in the Molecular Era: Integrating Cytology, Human Papillomavirus Testing, and Biomarkers
Journal of Cytology · 2026-04 · 43 (2) · 59-62
DOI: 10.4103/joc.joc_53_26 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Cytology, online erschienen am 16.05.2026. Verfasst von Nithye Parvathy und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Cervical cancer screening has evolved immensely with advances in molecular diagnostics and improved understanding of human papillomavirus (HPV)-mediated carcinogenesis. While conventional cervical cytology has historically played a pivotal role in reductions in cervical cancer incidence and mortality, its limitations have led to the development of liquid-based cytology (LBC) and HPV-based testing. LBC offers improved sample adequacy, better preservation of cellular morphology, and permits the use of residual material for ancillary testing. HPV DNA testing, particularly as a primary screening modality, provides high sensitivity for detecting high-grade cervical intraepithelial neoplasia. In addition, emerging biomarkers such as p16INK4a and Ki-67 dual staining enhance risk stratification and triage of HPV-positive women. Despite the growing adoption of primary HPV screening, cytology remains indispensable for morphologic assessment, detection of HPV-independent lesions, and clinical correlation. An integrated approach combining HPV testing, cytology, and biomarkers represents the most effective strategy for cervical cancer screening. Such a balanced model is essential for optimizing diagnostic accuracy, guiding management, and supporting global efforts toward cervical cancer elimination.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
- Department of Cytology and Gynecologic Pathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Zitieren
APA
Parvathy, N., & Gupta, N. (2026). Cervical Cancer Screening in the Molecular Era: Integrating Cytology, Human Papillomavirus Testing, and Biomarkers. Journal of Cytology, 43(2), 59-62. https://doi.org/10.4103/joc.joc_53_26
Vancouver
Parvathy N, Gupta N. Cervical Cancer Screening in the Molecular Era: Integrating Cytology, Human Papillomavirus Testing, and Biomarkers. Journal of Cytology. 2026;43(2):59-62. doi:10.4103/joc.joc_53_26
BibTeX
@article{Parvathy2026,
author = {Parvathy, Nithye and Gupta, Nalini},
title = {Cervical Cancer Screening in the Molecular Era: Integrating Cytology, Human Papillomavirus Testing, and Biomarkers},
journal = {Journal of Cytology},
year = {2026},
volume = {43},
number = {2},
pages = {59--62},
doi = {10.4103/joc.joc_53_26}
}
EUVIMED